Pacira Pharma (PCRX) Tops Q4 EPS by 12c, Revenue Beats; Offers FY20 Revenue Guidance
Go back to Pacira Pharma (PCRX) Tops Q4 EPS by 12c, Revenue Beats; Offers FY20 Revenue Guidance| PACIRA (NASDAQ: PCRX) | Delayed: 23.51 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.51 | 52 Week High | $80.25 | |||
| Open | $23.51 | 52 Week Low | $30.25 | |||
| Day High | $23.51 | P/E | N/A | |||
| Day Low | $23.51 | EPS | $-2.08 | |||
| Volume | 497 | |||||

